Abstract: The present disclosure relates to an anti-glucose-regulated protein 78 (GRP78) antibody or an antigen-binding fragment thereof. The present disclosure also relates to a method for treating and/or preventing a disease and/or disorder caused by or related to GRP78 activity or signaling, and a method or kit for detecting GRP78 or a cancer in a sample.
Type:
Application
Filed:
July 3, 2024
Publication date:
January 16, 2025
Applicant:
UCT BIOSCIENCE CO., LTD.
Inventors:
CHIA-CHENG WU, YA-WEI TSAI, TZU-YIN LIN, CHIA-HSIANG LO